AMGEN AND NSG BIOLABS ANNOUNCE GOLDEN TICKET TO BOOST SINGAPORE'S BIOTECH ECOSYSTEM & More News Here

Amgen is the inaugural sponsor of the NSG Tomorrow Programme that goals to help innovation amongst biotech startups in Southeast Asia

SINGAPORE, May 31, 2022 /PRNewswire/ — Amgen, a number one international biotechnology firm, and NSG BioLabs, Singapore’s largest and main biotechnology (biotech) incubator, right this moment introduced the launch of a 3-year Golden Ticket sponsorship. Amgen’s Golden Ticket sponsorship marks the primary of the NSG Tomorrow Program created to assist revolutionary biotech startups execute in direction of their imaginative and prescient.

As a part of the sponsorship, Amgen will help one “Golden Ticket” award annually for 3 years, offering winners with one 12 months of free residency in NSG Biolabs’ absolutely geared up turnkey BSL-2 laboratory in addition to extra facility advantages and connections to Amgen’s scientific and enterprise leaders. Companies and pre-incorporated tasks in Singapore that are conducting analysis in specialised biotech fields or growing novel medicines and therapeutics can apply to affix the aggressive programme. Areas of curiosity embody novel and transformational therapies to deal with oncology, inflammatory, hepatic and cardiometabolic ailments in addition to revolutionary analysis and biomanufacturing platforms. Amgen’s inside scientific committee selects the Golden Ticket winner following an interactive pitch occasion.

“Singapore is a leading innovation hub in Asia, with high-quality biomedical science performed at internationally renowned institutions based in the country. Recognizing the growing biotech ecosystem locally, and Amgen’s high-tech biopharmaceutical manufacturing footprint located in Singapore, our sponsorship of the Golden Ticket with NSG BioLabs aims to further foster early-stage life science companies and provide unique mentoring opportunities for local scientist-entrepreneurs. Amgen R&D and Operations teams are excited to partner with NSG BioLabs to support the burgeoning bioscience community in Singapore, and further enable emerging life-science startups,” mentioned Philip Tagari, Vice President Therapeutic Discovery, Amgen.

Amgen Singapore started operations in 2014 as Amgen’s first Next Generation biomanufacturing facility in Asia, heralding state-of-the-art efficiencies and revolutionary manufacturing of medicines in commercial-scale manufacturing. Working intently with healthcare suppliers and the group to handle the area’s rising healthcare wants, Amgen continues to drive innovation in science and biotechnology and to develop a pipeline of expert specialists and high quality biomedical careers for the Singapore biotech trade.

Since its launch in 2019, NSG has achieved a number of main milestones in its mission to empower revolutionary biotech corporations and improve the ecosystem in Singapore. In 2021, with web site 1 at full capability, the corporate doubled its facility functionality, enabling it to help extra biotech corporations by offering state-of-the-art gear and house, in addition to entry to a various and rising group of innovators and scientists. Residents at NSG embody giant multi-national corporations like Applied Materials, L’Oréal Research & Innovation and Oxford Nanopore Technologies and promising native startups like Engine Biosciences, ImmunoScape and PairX Bio. The startups at NSG have achieved notable breakthroughs, with over S$100 million in funds raised, main partnerships, and new product launches since 2020. NSG at present has over 20 native and worldwide resident corporations, specialising in a various vary of transformative applied sciences and life-changing functions resembling genome modifying, tissue engineering, mobile agriculture, most cancers immunotherapy, synthetic intelligence, artificial biology, neurodegeneration drug discovery, and COVID-19 diagnostics.

The COVID-19 pandemic and success in vaccine and therapeutic improvement have drawn international consideration to the biotech sector. Sector development is accelerating in Singapore with native analysis yielding fruit, native corporations increasing internationally and attaining key milestones, robust authorities help, and trade leaders establishing key industrial operations and manufacturing/manufacturing amenities within the nation. Yet, Singapore’s biotech startups proceed to face distinctive technical, structural, and cultural challenges in launching and rising.

“With our first-hand experience in both the Singapore and US biotech sectors, NSG BioLabs has a deep understanding of the challenges biotech startups face. It is vital that we support their work as it could lead to new life-changing medicines. It is in this spirit that we started NSG Tomorrow, and we are honoured that Amgen shares our vision to help biotech startups grow and facilitate Singapore’s development into an international biotech powerhouse,” mentioned Daphne Teo, CEO and Founder of NSG BioLabs.

For extra particulars concerning the NSG Tomorrow and Amgen Golden Ticket, go to nsgtomorrow.com and for extra details about NSG BioLabs, go to www.nsgbio.com 

About NSG BioLabs

Founded with a give attention to supporting early-stage biotech corporations, NSG BioLabs provides state-of-the-art gear, professionally managed operations, capital effectivity, the experience of world-class groups and international networks to incubate and help rising life sciences corporations. The conducive R&D setting accommodates absolutely geared up laboratory and workplace infrastructure throughout 22,000 sq ft within the prime location of Biopolis. 

With entry to a world community and a shared set of abilities and expertise with its strategic companions, NSG BioLabs ensures that biotech startups can execute on their cutting-edge analysis and improvement ecosystem in Singapore, resulting in the innovation of revolutionary applied sciences and merchandise that translate into breakthrough biotech ventures and affect for sufferers. 

About Amgen

Amgen is dedicated to unlocking the potential of biology for sufferers affected by critical diseases by discovering, growing, manufacturing, and delivering revolutionary human therapeutics. This strategy begins through the use of instruments like superior human genetics to unravel the complexities of illness and perceive the basics of human biology.

Amgen focuses on areas of excessive unmet medical want and leverages its experience to try for options that enhance well being outcomes and dramatically enhance folks’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of many world’s main impartial biotechnology corporations, has reached thousands and thousands of sufferers around the globe and is growing a pipeline of medicines with breakaway potential.

Media Enquiries

Redhill Communications, Singapore
[email protected]

SOURCE NSG BioLabs

I’ve tried to provide every kind of stories to all of you latest news today 2022 by this web site and you’re going to like all this information very a lot as a result of all of the information we at all times give on this information is at all times there. It is on trending subject and regardless of the newest information was

it was at all times our effort to succeed in you that you simply maintain getting the newest information and also you at all times maintain getting the knowledge of stories by us without spending a dime and in addition inform you folks. Give that no matter info associated to different varieties of information will likely be

made accessible to all of you so that you’re at all times related with the information, keep forward within the matter and maintain getting today news all varieties of information without spending a dime until right this moment to be able to get the information by getting it. Always take two steps ahead